Erythrocin Lactobionate (erythromycin lactobionate)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Erythromycin lactobionate is a macrolide antibiotic.
USES: Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic.
It works by stopping the growth of bacteria.
Generic name: erythromycin lactobionate
Pronunciation: (eh-rith-row-MY-sin lack-toe-BYE-oh-nate)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Erythrocin Lactobionate
Indications
The following indications are listed for Erythrocin Lactobionate:
- Bacterial Pneumonia
- Chlamydial Conjunctivitis
- Chlamydial Pneumonia
- Diphtheria
- Erythrasma
- Legionnaires' Disease
- Listeriosis
- Mycoplasmal Pneumonia
- Pertussis
- Pharyngitis Due To Streptococcus Pyogenes
- Pneumococcal Pharyngitis
- Pneumococcal Pneumonia
- Rheumatic Fever Prevention
- Skin And Skin Structure Infection
- Skin And Skin Structure Streptococcus Pyogenes Infection
- Staphylococcus Aureus Skin And Skin Structure Infection
Also known as: Diphtheritis, Eaton Agent Pneumonia, Epidemic Sore Throat, Infection Due To Listeria Monocytogenes, Infection Of Skin And/Or Subcutaneous Tissue, Infection Of The Lungs Due To Chlamydia, Legionellosis, Pharyngitis Due To Group A Beta-Hemolytic Streptococci, Pharyngitis Due To Streptococcus Epidemicus, Pharyngitis Due To Streptococcus Pneumoniae, Pneumonia Due To Streptococcus Pneumoniae, Primary Atypical Pneumonia, Rheumatic Fever Prophylaxis, Septic Sore Throat, Skin & Skin Soft Tissue Streptococcus Pyogenes Infection, Skin And Skin Soft Tissue Staphylococcus Aureus Infection, Skin And Soft Tissue Skin Infection, Streptococcal Pharyngitis, Syriac Ulcer.
Dosing
Dosage of erythromycin lactobionate is expressed in terms of erythromycin.
The usual dosage of erythromycin as the lactobionate for severe infections in adults and children is 15-20 mg/kg daily, given as a continuous IV infusion or by intermittent IV infusion in divided doses every 6 hours. Alternatively, a pediatric dosage of 300-600 mg/m2 daily has been recommended. Dosages as high as 4 g daily have been used in very severe infections.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.